FDA Approved: CISPLATIN — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved the original application for cisplatin from Apotex Corp., enabling the generic version to be marketed in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Testicular Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

ORIG AP for CISPLATIN (CISPLATIN)